NCT03368703View on ClinicalTrials.gov

Physiopathology of Lower Cortical Activation in COPD Patients: Contribution of Cortical Neuromodulation

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Physiology
Interventions
DEVICE

Anodal transcranial direct-current-stimulation

2mA / 20min Anodal and Sham tDCS over dominant M1. Anodal tDCS consists of 30s of ramp up followed by 20min of stimulation and 30s of ramp down.

DEVICE

Sham transcranial direct-current-stimulation

"Sham tDCS consists of only 30s of ramp up followed by 30s of ramp down and no further stimulation.~Participants therefore have the same feeling for both modalities : slight itching due to the induced current at the beginning of the protocol (during around 30s) allowing no differentiation by the participant between the anodal or sham sessions."

Trial Locations (1)

34700

Cliniques du Souffle, Lodève

All Listed Sponsors
lead

5 Santé

OTHER

NCT03368703 - Physiopathology of Lower Cortical Activation in COPD Patients: Contribution of Cortical Neuromodulation | Biotech Hunter | Biotech Hunter